mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.7 |
mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.7 |
mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |